Endurance Wealth Management, Inc. Abb Vie Inc. Transaction History

Endurance Wealth Management, Inc.

$731 Million
Q2 2023

A detailed history of Endurance Wealth Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Endurance Wealth Management, Inc. holds 102,116 shares of ABBV stock, worth $19.8 Million. This represents 1.88% of its overall portfolio holdings.

Number of Shares

102,116

Previous 101,277 0.83%

Holding current value

$19.8 Million

Previous $16 Million 13.92%

% of portfolio

1.88%

Previous 2.27%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$132.51 - $164.9 $111,175 - $138,351	839 Added 0.83%	102,116 $13.8 Million
Q1 2023 May 02, 2023	BUY	$144.61 - $166.54 $277,217 - $319,257	1,917 Added 1.93%	101,277 $16 Million
Q4 2022 Feb 01, 2023	BUY	$138.31 - $165.87 $73,027 - $87,579	528 Added 0.53%	99,360 $16.1 Million
Q3 2022 Oct 21, 2022	BUY	$134.21 - $153.93 $17,313 - $19,856	129 Added 0.13%	98,832 $13.3 Million
Q2 2022 Jul 20, 2022	SELL	$137.62 - $174.96 $139,684 - $177,584	-1,015 Reduced 1.02%	98,703 $15.1 Million
Q1 2022 Apr 20, 2022	SELL	$131.98 - $163.75 $787,392 - $976,932	-5,966 Reduced 5.65%	99,718 $16.2 Million
Q4 2021 Jan 19, 2022	SELL	$107.43 - $135.93 $776,504 - $982,502	-7,228 Reduced 6.4%	105,684 $14.3 Million
Q3 2021 Oct 28, 2021	SELL	$106.4 - $120.78 $83,417 - $94,691	-784 Reduced 0.69%	112,912 $12.2 Million
Q2 2021 Aug 04, 2021	BUY	$105.21 - $117.21 $71,437 - $79,585	679 Added 0.6%	113,696 $12.8 Million
Q1 2021 May 05, 2021	BUY	$102.3 - $112.62 $347,001 - $382,007	3,392 Added 3.09%	113,017 $12.2 Million
Q4 2020 Jan 15, 2021	BUY	$80.49 - $108.67 $49,903 - $67,375	620 Added 0.57%	109,625 $11.7 Million
Q3 2020 Oct 27, 2020	BUY	$85.91 - $100.83 $601,370 - $705,810	7,000 Added 6.86%	109,005 $9.55 Million
Q2 2020 Jul 14, 2020	BUY	$73.37 - $98.18 $340,950 - $456,242	4,647 Added 4.77%	102,005 $10 Million
Q1 2020 May 11, 2020	BUY	$64.5 - $97.79 $200,917 - $304,615	3,115 Added 3.31%	97,358 $7.42 Million
Q4 2019 Jan 14, 2020	BUY	$72.13 - $90.25 $674,704 - $844,198	9,354 Added 11.02%	94,243 $8.34 Million
Q3 2019 Oct 18, 2019	SELL	$62.98 - $75.72 $125,393 - $150,758	-1,991 Reduced 2.29%	84,889 $6.43 Million
Q2 2019 Jul 30, 2019	BUY	$65.7 - $83.98 $60,115 - $76,841	915 Added 1.06%	86,880 $6.32 Million
Q1 2019 May 01, 2019	SELL	$77.14 - $90.79 $143,403 - $168,778	-1,859 Reduced 2.12%	85,965 $6.93 Million
Q4 2018 Jan 14, 2019	BUY	$77.85 - $96.01 $118,409 - $146,031	1,521 Added 1.76%	87,824 $8.1 Million
Q3 2018 Oct 10, 2018	SELL	$88.91 - $98.84 $84,464 - $93,898	-950 Reduced 1.09%	86,303 $8.16 Million
Q2 2018 Aug 02, 2018	SELL	$89.78 - $106.23 $53,868 - $63,738	-600 Reduced 0.68%	87,253 $8.08 Million
Q1 2018 Apr 19, 2018	SELL	$92.01 - $123.21 $183,927 - $246,296	-1,999 Reduced 2.22%	87,853 $8.32 Million
Q4 2017 Jan 18, 2018	SELL	$89.56 - $98.21 $1.2 Million - $1.32 Million	-13,450 Reduced 13.02%	89,852 $8.69 Million
Q3 2017 Oct 19, 2017	BUY	$69.85 - $89.22 $7.22 Million - $9.22 Million	103,302	103,302 $9.18 Million

Others Institutions Holding ABBV

# of Institutions

3,689

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $342B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurance Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Endurance Wealth Management, Inc. with notifications on news.

Account

Endurance Wealth Management, Inc. Abb Vie Inc. Transaction History